Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/sdi.12980 http://scihub22266oqcxt.onion/10.1111/sdi.12980 33969909!8206973!33969909     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33969909&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Semin+Dial 2021 ; 34 (3): 257-262 Nephropedia Template TP {{tp|p=33969909|t=2021. Extracorporeal CO(2) removal and renal replacement therapy in acute severe respiratory failure in COVID-19 pneumonia: Case report |pdf=|usr=}}{{33969909}} gab.com Text Extracorporeal CO(2) removal and renal replacement therapy in acute severe respiratory failure in COVID-19 pneumonia: Case report JO: Semin Dial http://www.kidney.de/pget.php?&tw=1&pmid=33969909 #FOAvip The COVID-19 pandemic significates an enormous number of patients with pneumonia that get complicated with severe acute respiratory distress syndrome (ARDS), some of them with refractory hypercapnia and hypoxemia that need mechanical ventilation (MV). Those patients who are not candidate to extracorporeal membrane oxygenation (ECMO), the extracorporeal removal of CO(2) (ECCO(2) R) can allow ultra protective MV to limit the transpulmonary pressures and avoid ventilatory induced lung injury (VILI). We report a first case of prolonged ECCO(2) R support in 38 year male with severe COVID-19 pneumonia refractory to conventional support. He was admitted tachypneic and oxygen saturation 71% without supplementary oxygen. The patient's clinical condition worsens with severe respiratory failure, increasing the oxygen requirement and initiating MV in the prone position. After 21 days of protective MV, PaCO(2) rise to 96.8 mmHg, making it necessary to connect to an ECCO(2) R system coupled continuous veno-venous hemodialysis (CVVHD). However, due to the lack of availability of equipment in the context of the pandemic, a pediatric gas exchange membrane adapted to CVVHD allowed to maintain the removal of CO(2) until completing 27 days, being finally disconnected from the system without complications and with a satisfactory evolution. Twit Text FOAVip Extracorporeal CO(2) removal and renal replacement therapy in acute severe respiratory failure in COVID-19 pneumonia: Case report ????Semin Dial http://www.kidney.de/pget.php?&tw=1&pmid=33969909 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33969909 #FOAvip English Wikipedia <ref>{{Cite pmid|33969909}}</ref> Extracorporeal CO(2) removal and renal replacement therapy in acute severe respiratory failure in COVID-19 pneumonia: Case report #MMPMID33969909 Gacitua I; Frias A; Sanhueza ME; Bustamante S; Cornejo R; Salas A; Guajardo X; Torres K; Figueroa Canales E; Tobar E; Navarro R; Romero C Semin Dial 2021[May]; 34 (3): 257-262 PMID33969909show ga The COVID-19 pandemic significates an enormous number of patients with pneumonia that get complicated with severe acute respiratory distress syndrome (ARDS), some of them with refractory hypercapnia and hypoxemia that need mechanical ventilation (MV). Those patients who are not candidate to extracorporeal membrane oxygenation (ECMO), the extracorporeal removal of CO(2) (ECCO(2) R) can allow ultra protective MV to limit the transpulmonary pressures and avoid ventilatory induced lung injury (VILI). We report a first case of prolonged ECCO(2) R support in 38 year male with severe COVID-19 pneumonia refractory to conventional support. He was admitted tachypneic and oxygen saturation 71% without supplementary oxygen. The patient's clinical condition worsens with severe respiratory failure, increasing the oxygen requirement and initiating MV in the prone position. After 21 days of protective MV, PaCO(2) rise to 96.8 mmHg, making it necessary to connect to an ECCO(2) R system coupled continuous veno-venous hemodialysis (CVVHD). However, due to the lack of availability of equipment in the context of the pandemic, a pediatric gas exchange membrane adapted to CVVHD allowed to maintain the removal of CO(2) until completing 27 days, being finally disconnected from the system without complications and with a satisfactory evolution. |*Renal Replacement Therapy[MESH] |Adult[MESH] |COVID-19/*therapy[MESH] |Carbon Dioxide/*metabolism[MESH] |Humans[MESH] |Male[MESH] |Pandemics[MESH] |Pneumonia, Viral/*therapy/*virology[MESH] |Respiratory Insufficiency/*therapy/*virology[MESH]Extracorporeal CO(2) removal and renal replacement therapy in acute se(epmc).pdf DeepDyve Pubget Overpricing